Moreover, in a model of a patient receiving a tumor antigen-specific vaccine, brachyury-specific CD8+ T cells increased PD-L1 expression on chordoma cells through the production of IFN-γ, increasing the sensitivity of chordoma cells to avelumab-mediated ADCC. This evidence concerns the gene TBX1 and neoplasm.